Strategic Advisors
Deborah Ancona, PhD Seley Distinguished Professor of Management; Professor of Organization Studies; Faculty Director, MIT Leadership Center, MIT Sloan School of Management |
Retsef Levi, PhD J. Spencer Standish (1945) Professor of Management; Associate Professor of Operations Management, MIT Sloan School of Management |
Denny A. Ausiello, MD CATCH Co-Founder, Director; Jackson Professor of Clinical Medicine, Harvard Medical School; Chief of Medicine, MGH; Director, Pfizer |
Andrew Lo, PhD Charles E. and Susan T. Harris Professor of Finance; Director, Laboratory for Financial Engineering, MIT Sloan School of Management |
Ernest Berndt, PhD, MS Louis E Seley Professor of Applied Economics, Sloan School of Management; Co-director Biomedical Enterprise Program |
Alex 'Sandy' Pentland, PhD Professor of Media Arts and Sciences, Toshiba Professor, MIT Media Lab; Director, MIT Media Lab Entrepreneurship Program |
Charles L. Cooney, PhD Robert T. Haslam Professor of Chemical Engineering, MIT; Faculty Director, Deshpande Center for Technological Innovation |
Ram Sasisekharan, PhD Director, Harvard – MIT Health Sciences and Technology, Edward Hood Taplin Professor of Health Sciences & Technology and Biological Engineering, MIT |
Michael A. Cusumano, PhD Sloan Management Review Distinguished Professor of Management, MIT Sloan School of Management |
Phillip A. Sharp, PhD Institute Professor, Koch Institute for Integrative Cancer Research, MIT |
Elazer Edelman, MD, PhD, FACC Thomas D & Virginia W Cabot Professor of HST, Health Sciences and Technology Program, MIT |
Anthony Sinskey, ScD Faculty Director, CBI; Professor of Biology and Health Sciences and Technology, MIT |
Executive Advisory Network
The role of the Executive Advisory Network is to contribute ideas for projects, vet new opportunities, and disseminate emerging insights and recommendations from NEWDIGS activities. The Executive Advisory Network will assist with outreach to potential sponsors and endorse the goals of NEWDIGS projects as well the alignment of new projects with NEWDIGS mission and priorities; It has no financial or fiduciary responsibility, nor does it make any product-specific decisions. Typical agenda items include research updates, workshop opportunities, new mini-consortia proposals and pending publications.
Nick Crabb, PhD Program Director, Scientific Affairs National Institute for Health & Clinical Excellence (NICE) |
Peter L. Saltonstall President and CEO National Organization for Rare Disorders (NORD) |
Anne-Virginie Eggimann, MSc Vice President, Regulatory Science bluebird bio |
Harry Selker, MD, MSPH Dean, Clinical and Translational Science Institute Institute for Clinical Research & Health Policy Studies Tufts University |
Hans-Georg Eichler, MD, MSc Senior Medical Officer European Medicines Agency |
David R. Strutton, PhD Vice President of Global Pharmaceuticals and Policy Research, Center for Observational and Real-World Evidence, Merck & Co., Inc. |
Gigi Hirsch, MD Executive Director, Center for Biomedical Innovation, NEWDIGS |
Mark Trusheim, MSc Strategic Director, NEWDIGS; Visiting Scientist, Sloan School of Management Massachusetts Institute of Technology; President, Co-Bio Consulting |
Kenneth A. Oye, PhD Associate Professor of Political Science and Engineering Systems;; Co-Director, MIT Program on Emerging Technologies Massachusetts Institute of Technology |
Affiliated Faculty and Researchers
Jane F. Barlow, MD, MPH, MBA Senior Advisor, MIT Center for Biomedical Innovation: NEWDIGS; Financing and Reimbursement of Cures in the US (FoCUS) Project; CEO, Jane Barlow & Associates |
Judy Maro, PhD, MS Research Affiliate, Center for Biomedical Innovation, Research Fellow in the Department of Population Medicine at Harvard Medical School and the Harvard Pilgrim Health Care Institute |
Ernest Berndt, PhD, MS Louis E Seley Professor of Applied Economics, Sloan School of Management; Co-director Biomedical Enterprise Program |
Kenneth A. Oye, PhD Associate Professor of Political Science and Engineering Systems;; Co-Director, MIT Program on Emerging Technologies Massachusetts Institute of Technology |
Stella Blackburn, MD, MA, MSc Senior Advisor, Regulatory Science, NEWDIGS; Honorary Associate Professor, London School of Hygiene & Tropical Medicine; Vice President, Global Head of Early Access and Risk Management, IQVIA |
Nitin R. Patel, PhD Research Affiliate, MIT Center for Biomedical Innovation; Founder, Chairman, and Chief Technology Officer, Cytel Statistical Software and Services |
Jeff Brown, PhD Assistant Professor, Department of Population Medicine, Harvard Medical School |
Casey Quinn, PhD Research Advisor, MIT Center for Biomedical Innovation: NEWDIGS; Financing and Reimbursement of Cures in the US (FoCUS) Project |
Chester Drum, MD, PhD Assistant Professor, Department of Medicine, National University of Singapore |
G.K. Raju, PhD CBI Distinguished Fellow; Chairman, CBI Biomanufacturing Steering Committee; Executive Director, MIT Pharmaceutical Manufacturing Initiative |
R. John Glasspool Senior Advisor, MIT Center for Biomedical Innovation: NEWDIGS; Financing and Reimbursement of Cures in the US (FoCUS) Project |
Mark Trusheim, MSc Strategic Director, NEWDIGS; Visiting Scientist, Sloan School of Management Massachusetts Institute of Technology; President, Co-Bio Consulting |
NEWDIGS Program Leadership
Azrina Azhar, MS, MPA azrina@mit.edu Operations Manager, NEWDIGS 617-324-9640 |
Eric A. Small easmall@mit.edu Senior Administrative Assistant, NEWDIGS; Assistant to Executive Director Gigi Hirsch 617-324-4841 |
David P. Fritsche, MBA dpfritsc@mit.edu Technology Officer, Learning Ecosystems Accelerator for Patient-centered & Sustainable (LEAPS) Innovation Project 617-324-7763 |
Mark Trusheim, MSc trusheim@mit.edu Strategic Director, NEWDIGS; Visiting Scientist, Sloan School of Management Massachusetts Institute of Technology; President, Co-Bio Consulting |
Gigi Hirsch, MD ghirsch@mit.edu Executive Director, Center for Biomedical Innovation, NEWDIGS 617-253-9609 |
Colin Young, PhD colyoung@mit.edu Director, Drug Development Pipeline Research, Financing and Reimbursement of Cures in the US (FoCUS) 617-324-7261 |
Kay Larholt, ScD klarholt@mit.edu Director of Research, NEWDIGS 617-253-7333 |
FoCUS Project Team
Financing and Reimbursement of Cures in the U.S.
Jane F. Barlow, MD, MPH, MBA
Senior Advisor, MIT Center for Biomedical Innovation: NEWDIGS; Financing and Reimbursement of Cures in the US (FoCUS) Project; CEO, Jane Barlow & Associates |
Eric A. Small
Senior Administrative Assistant, NEWDIGS; Assistant to Executive Director Gigi Hirsch 617-324-4841 |
R. John Glasspool
Senior Advisor, MIT Center for Biomedical Innovation: NEWDIGS; Financing and Reimbursement of Cures in the US (FoCUS) Project |
Katie Torrence
Project Coordinator, Financing and Reimbursement of Cures in the US (FoCUS) 617-324-2695 |
Gigi Hirsch, MD
Executive Director, Center for Biomedical Innovation, NEWDIGS 617-253-9609 |
Mark Trusheim, MSc
Strategic Director, NEWDIGS; Visiting Scientist, Sloan School of Management Massachusetts Institute of Technology; President, Co-Bio Consulting |
Casey Quinn, PhD
Research Advisor, MIT Center for Biomedical Innovation: NEWDIGS; Financing and Reimbursement of Cures in the US (FoCUS) Project |
Colin Young, PhD
Director, Drug Development Pipeline Research, Financing and Reimbursement of Cures in the US (FoCUS) 617-324-7261 |
LEAPS Project Team
Fiona X. Cai
Researcher, Learning Ecosystems Accelerator for Patient-centered & Sustainable (LEAPS) Innovation Project |
Kay Larholt, ScD
Director of Research, NEWDIGS 617-253-7333 |
David P. Fritsche, MBA
Technology Officer, Learning Ecosystems Accelerator for Patient-centered & Sustainable (LEAPS) Innovation Project 617-324-7763 |
Mitesh Puthran
Data Analyst, Learning Ecosystems Accelerator for Patient-centered & Sustainable (LEAPS) Innovation Project |
Gigi Hirsch, MD
Executive Director, Center for Biomedical Innovation, NEWDIGS 617-253-9609 |
Eric A. Small
Senior Administrative Assistant, NEWDIGS; Assistant to Executive Director Gigi Hirsch 617-324-4841 |
Keileen Hopps, MPA
Project Coordinator, Learning Ecosystems Accelerator for Patient-centered & Sustainable (LEAPS) Innovation Project 617-324-7763 |
Mark Trusheim, MSc
Strategic Director, NEWDIGS; Visiting Scientist, Sloan School of Management Massachusetts Institute of Technology; President, Co-Bio Consulting |
Strategic Advisory Network
Anna D. Barker, PhD Co-Director, Complex Adaptive Systems (CAS); Director, National Biomarker Development Alliance (NBDA); Professor, School of Life Sciences, Arizona State University (ASU) |
Secretary Marylou Sudders, MS, Hon.DSc Secretary of Health and Human Services, Commonwealth of Massachusetts |
Alex 'Sandy' Pentland, PhD Professor of Media Arts and Sciences, Toshiba Professor, MIT Media Lab; Director, MIT Media Lab Entrepreneurship Program |
Peter Szolovits, PhD Professor, Department of Electrical Engineering and Computer Science (EECS), Institute for Medical Engineering and Science (IMES), Massachusetts Institute of Technology |
Richard Platt, MD, MSc Executive Director, Harvard Pilgrim Health Care Institute, Department of Population Medicine, Harvard Medical School |
Susan Windham-Bannister, PhD President & CEO, Biomedical Growth Strategies LLC; Managing Partner, Biomedical Innovation Advisors LLC |
Michael S. Sherman, MD, MBA, MS, CPE Senior Vice President & Chief Medical Officer; Harvard Pilgrim Health Care |
Janet Woodcock, MD Director, Center for Drug Evaluation and Research, US Food and Drug Administration |